GeroScience · Nov 16, 2026
Prevalent atherosclerotic cardiovascular disease is associated with osteoporosis and osteopenia in people referred for bone mineral density testing
By Smith C, Sim M, Schousboe JT et al.
Osteoporosis and atherosclerotic cardiovascular disease (ASCVD) are common in older adults. This cross-sectional study examined whether ASCVD prevalence differs by bone mineral density (BMD) category in the Manitoba BMD registry (n = 86,991 adults, mean age 64.7 ± 11.0 years, 90.2% women). Total hip (TH), femoral neck (FN), and lumbar spine (LS) BMD was assessed by dual-energy X-ray absorptiometry and categorized from T-score as normal (≥ − 1), osteopenia (− 1.0 to − 2.5), or osteoporosis (≤ − 2.5). Prevalent ASCVD (hospitalized coronary artery disease, acute myocardial infarction, non-hemorrhagic cerebrovascular disease, peripheral arterial disease; coronary revascularization; and/or congestive heart failure) was ascertained from linked data. Multivariable adjusted logistic regression assessed associations. Among individuals, 10.7% had prevalent ASCVD, 39.1% had osteopenia, and 8.6% had osteoporosis. ASCVD prevalences for the normal, osteopenia, and osteoporosis groups were 9.2%, 11.2%, and 18.2%, respectively. Compared to normal BMD, osteopenia and osteoporosis were associated with higher odds of prevalent ASCVD adjusted for fracture risk factors (OR 1.09, 95% CI 1.03–1.15; OR 1.37, 95% CI 1.27–1.49). Associations persisted with further adjustment for cardiometabolic and socioeconomic factors (osteopenia OR 1.18, 95% CI 1.12–1.25; osteoporosis OR 1.59, 95% CI 1.46–1.73). In stratified analyses, ORs were greater in individuals aged 40–64 versus ≥ 65 years (p =< 0.001); no differences were observed for sex (p = 0.225). Similar results were seen at the FN but were inconsistent for the LS. ASCVD is a common comorbid condition with osteopenia, but more so osteoporosis in a routine BMD examination setting. Osteopenia or osteoporosis documentation represents an opportunity for optimized risk factor management, perhaps altering disease trajectory.
doi.org/10.1007/s11357-026-02650-9PubMed 43037916Populations